SecBot SecBot
Insider Cluster (4 insiders) ·Filed Sep 15, 2026

PHVS

Pharvaris N.V.
BEARISH
Impact 5/10
Horizonweeks Processed2mo ago
Insider cluster: 4 insiders, $2.1M total
Actionable Insight ▼ Bearish

The cluster of sales by the CEO, President, and Chief Early Development Officer, while not massive relative to market cap, is a bearish signal given the lack of any insider buying. Traders should monitor for upcoming clinical data readouts or corporate developments that may have prompted the selling. The stock's strong recent performance (90% analyst bullish) may have created a selling opportunity for insiders, but the concentration of sales by top executives warrants caution.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$38.06
T+0 close · Sep 15, 2026 · via day close
Latest settled
−21.12%
T+20 · $30.02 · next T+60 in 22d
Vs SPY
−24.10%
α at T+20
Latest observation
−9.88%
T+43 · FF3 residual α
  1. T+0 · Sep 15 $38.06entry
  2. T+1 · 2mo ago −0.41%α −0.73% · $37.91
  3. T+5 · 8w ago −4.44%α −5.26% · $36.37
  4. T+20 · 5w ago −21.12%α −24.10% · $30.02
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four Pharvaris insiders, including the CEO and President, sold a total of $2.15M in open-market shares over a 7-day window. The CEO's sale of $90K is small, but the President's $610K sale and the Chief Early Development Officer's $1.15M sale are material. The cluster is entirely sells with no buys, and the dollar value represents ~0.08% of the $2.7B market cap, falling just below the 0.1% threshold for materiality. However, the presence of derivative exercises (non-cash) preceding some sales suggests tax-related planning, but the open-market sales by senior executives are a cautionary signal for a biotech trading near its 52-week high with a 90% bullish analyst consensus.

Key Financial Metrics

Direction
selling
Total Value
$2.1M
Insiders
4

Key Facts

  • CEO Modig Berndt sold 2,291 shares for $90,276 on 2026-09-14.
  • President Lu Peng sold 15,000 shares for $610,200 on 2026-09-08.
  • Chief Early Development Officer Lesage Anne sold 30,000 shares for $1,149,084 on 2026-09-10, after exercising derivatives.
  • Director Glassman Robert sold 8,000 shares for $300,396 on 2026-09-09, after exercising derivatives.
  • Total insider sales in the cluster: $2.15M, representing ~0.08% of the $2.7B market cap.
  • No insider purchases were made during the cluster window.

Financial Impact

Total insider sales of $2.15M, or ~0.08% of market cap, concentrated among senior executives.

insider ownershipmarket sentiment

Risk Factors

  • Insider selling may signal management's lack of confidence in near-term catalysts or valuation.
  • The stock is trading near a potential peak with high bullish consensus, increasing downside risk if sentiment shifts.
  • No insider buying to offset the selling cluster suggests a one-sided bearish view from those closest to the business.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1789496156446

Track record

51 reports on PHVS

Performance horizon

14 of 17 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
  3. Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  4. Nov 12, 20264d ago 6-K Neutral 4/10 No price data
  5. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  6. Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
  7. Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  8. Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  9. Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
  10. Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
Showing 10 of 51

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026